Pharmaceuticals and healthcare
Accelerate innovation by identifying strategic partnerships, fast.
Explore insights on over 50M companies, 160M patents, and 550k clinical trials in one powerful platform. Turn data into opportunities and act with confidence.
Leading innovation challenges for pharmaceutical companies.
Say goodbye to generic databases and incomplete intel, say hello to personalization, efficiency and accuracy you never thought possible.
Challenge 1.
Valuing innovation amid market uncertainty
Early-stage assets and breakthrough science carry enormous promise, but also unpredictable clinical, regulatory, and market risks that make accurate valuation difficult.
Challenge 2.
Coordinating scouting across global teams
Innovation, M&A and CVC teams often pursue overlapping opportunities, but organizational silos and differing priorities can slow or derail critical decisions.
Challenge 3.
Assessing Early-stage potential with limited data
Emerging biotech and medtech companies often have sparse clinical results, making it hard to judge their true scientific and commercial viability.
21x
Find critical company information 21x faster
97%
Reduce the risk of missing a perfect fit by 97%
50m+
Companies from over 200 jurisdictions worldwide
Trusted by the world's biggest pharmaceutical companies.
How FounderNest helps
Turning global scouting challenges into strategic advantages.
Accelerating discovery of high-potential biotechs.
Our AI-powered scouting surfaces emerging biotech, medtech, and digital health companies worldwide, even those in early-stage growth so pharmaceutical innovation teams can spot promising technologies before competitors.
Unmatched clinical trial intelligence.
Tap into a database of over 160 million patents, and 550k clinical trial records worldwide, giving you instant visibility into study phases, outcomes, and competitive landscapes to evaluate potential partners with precision.
Coordinating global scouting efforts.
FounderNest centralizes intelligence so regional and functional teams share a single view of targets, avoiding duplicate outreach and enabling faster, unified decision-making on partnerships, licensing, or acquisitions.
“FounderNest has become an essential tool for us, sharpening our innovation edge and propelling Novo Nordisk towards the future of healthcare.”
Lluc Diaz
Director, Digital Innovation
Frequently asked questions:
- How does FounderNest identify emerging pharmaceutical or healthcare companies that aren’t already on our radar?
FounderNest uses AI-driven search across the most comprehensive global datasets, including stealth startups, niche markets, and non-English sources to uncover opportunities before they appear in traditional industry databases.
- Can FounderNest integrate with existing scouting and CRM tools?
Yes, FounderNest offers flexible API and platform integrations so your teams can access market intelligence directly within your existing workflows and collaboration systems.
- How current and reliable is your data, especially for clinical trials and regulatory filings?
Our database aggregates over 160 million patents and clinical trial records and continuously updates from verified global sources, including regulatory agencies, patent offices, and company disclosures.
- How does FounderNest support cross-border scouting and compliance checks?
We provide multi-region coverage and regulatory intelligence to assess risks in different markets, helping teams navigate local compliance, IP issues, and market entry challenges.
- What makes FounderNest different from other life sciences databases?
Unlike static databases, FounderNest applies AI to connect company, clinical, patent, and funding data, revealing hidden relationships and early signals of high-potential innovation.
Insights
Uncover the 20% of opportunities others miss.
Join companies like L'Oreal, Roche and Telefonica to supercharge your market intelligence and be one-step ahead of your competition.
FounderNest is an AI market intelligence platform that helps large corporations discover, analyze, and evaluate new markets, trends, and companies, making decisions faster and more strategically.